Printing the Future of Therapeutics in 3D
May 4-6, 2020
Peter Wall Institute for Advanced Studies
Vancouver, BC, Canada
FOSTERING RELATIONSHIPS AND DEVELOPING COLLABORATIONS
PFT3D is an exclusive roundtable event centred around facilitating discussion and collaboration on the development of commercially and clinically relevant life-saving tissues.
SYMPOSIUM INFORMATION
Aspect Biosystems and The University of British Columbia are proud to be co-organizing the fourth annual international symposium on Printing the Future of Therapeutics in 3D (PFT3D).
Last year’s inaugural event saw speakers from a wide variety of both academia and industry to discuss the amazing potential and applications of 3D bioprinting. This year, the event will take place over 3 days and includes 20 speakers, covering four key areas:
Functional biofabricated tissues for disease modeling, therapeutic discovery, and regenerative medicine
Platform technologies to recreate biological function
Biomaterials for the development of functional tissues
An industry perspective on tissue engineering technologies
By the end of this meeting, we want you to leave with new inspirational ideas on groundbreaking projects, new partners and opportunities for collaboration, and a fresh perspective on the needs of industry and the translation of academic research.
In addition to our roundtable talks, there will be focused discussion sessions to address a variety of key challenges in our industry and facilitated networking sessions to stimulate interactions.
2019 SPEAKERS & PANELLISTS
(2020 TBA)
Organizing Committee
Tamer Mohamed
President & CEO, Aspect Biosystems
Peter Zandstra
Director & Professor, UBC School of Biomedical Engineering
Sam Wadsworth
Chief Scientific Officer, Aspect Biosystems
Natalie Korenic
Marketing & Communications Manager, Aspect Biosystems
Speakers & Panellists
Nureddin Ashammakhi
Co-Director, Institute for Minimally Invasive Therapeutics, David Geffen School of Medicine, UCLA
R. Lee Buckler
President & CEO, RepliCel Life Sciences, Inc.
Heather Burkin
Assistant Professor, Department of Pharmacology University of Nevada, Reno School of Medicine
Jason Ekert
Head Complex In Vitro Models, In Vitro/In Vivo Translation, Research, GlaxoSmithKline
Spiro Getsios
VP, Tissue Engineering, Aspect Biosystems
Paul C. Goodwin
Science Director, GE Healthcare, Life Sciences
Ken-ichi Hamada
Program Manager, JSR-Keio University Medical and Chemical Innovation Center, JSR Corporation
Jinah Jang
Assistant Professor, Pohang University of Science and Technology (POSTECH)
Anna Jezierski
Research Officer, Human Health Therapeutics Research Centre, National Research Council of Canada
Timothy J. Kieffer
Professor, Cellular & Physiological Sciences and Surgery, University of British Columbia, Diabetes Research Group Leader, School of Biomedical Engineering, Life Sciences Institute
Todd A. Lorenz
Partner, Intellectual Property & Technology, Squire Patton Boggs
Faisal M. Mirza
Surgeon, Artist, Author, Entrepreneur, OrthoSynthesis Inc.
Carlos Mota
Assistant Professor, Maastricht University, MERLN Institute, Dept. of Complex Tissue Regeneration, The Netherlands
Massimiliano Paganelli
Pediatric Hepatologist, Sainte-Justine University Hospital Center, Assistant Professor of Pediatrics, Université de Montréal, Founder, Morphocell Technologies Inc.
Fabio Rossi
Professor, Medical Genetics and Biomedical Engineering, University of British Columbia, Director of the Biomedical Research Centre and Director of Research of the School of Biomedical Engineering
Venu Varanasi
Associate Professor, Department of Graduate Nursing, Department of Materials Science and Engineering, University of Texas at Arlington
Adrian West
Assistant Professor, Department of Physiology and Pathophysiology, University of Manitoba
Stephanie Willerth
Associate Professor and Canada Research Chair in Biomedical Engineering, University of Victoria
Tim Woodfield
Assoc Professor, University of Otago, New Zealand Director CReaTE Group, Department of Orthopaedic Surgery Director UOtago Centre for Bioengineering & Nanomedicine
Yu Shrike Zhang
Assistant Professor, Department of Medicine, Harvard Medical School
2018 SPEAKERS
- Elizabeth Aisenbrey
Postdoctoral Trainee in Vascular Surgery and Biomedical Engineering, University of Wisconsin - David Ballard
Radiology Resident, Mallinckrodt Institute of Radiology, Washington University School of Medicine - Andreas R. Baudy
Assoc. Principal Scientist, Safety Assessment Department, Merck & Co., Inc - Robert A. Blake
Scientist in Biochemical and Cellular Pharmacology, Genentech, Inc. - Akhilesh K. Gaharwar
Assistant Professor of Biomedical Engineering, Texas A&M University - Sepideh H. Hagvall
Associate Principal Scientist, AstraZeneca and Adjunct Professor in Molecular Biology, Skövde University, Sweden
- Jeremy Hirota
Canada Research Chair in Respiratory Mucosal Immunology, Assistant Professor of Medicine – McMaster University, Assistant Professor of Medicine (Affiliate) – UBC - Jinah Jang
Assistant Professor, Pohang University of Science and Technology (POSTECH) - Anna Jezierski
Research Scientist, Human Health Therapeutics, National Research Council Canada - Jean-Louis Klein
Director, Target & Pathway Validation, GlaxoSmithKline - Tamer Mohamed
President & CEO, Aspect Biosystems - John F. Trant
Assistant Professor, Department of Chemistry and Biochemistry and the Canadian Centre for Alternatives to Animal Methods, University of Windsor
- Stephanie Willerth
Associate Professor and Canada Research Chair in Biomedical Engineering, University of Victoria - Bill Yackabonis
Technical Manager, Autodesk - Peter Zandstra
Director, School of Biomedical Engineering and Professor, Department of Medical Genetics, UBC - Boyang Zhang
Assistant Professor, Department of Chemical Engineering, McMaster University - Yu Shrike Zhang
Associate Bioengineer and Faculty, Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
VENUE & HOSTS
We are proud to be hosting this International Research Roundtable at the Peter Wall Institute for Advanced Studies on the beautiful University of British Columbia (UBC) campus in Vancouver, BC.
Aspect Biosystems is a privately held biotechnology company pioneering microfluidic 3D bioprinting of living, human tissue. The company’s proprietary technology is enabling advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine. In addition to its internal programs, Aspect is focused on strategically partnering with pharmaceutical and biotechnology companies, as well as academic researchers, to enable the creation of living, human tissues for medical research, therapeutic discovery, and regenerative medicine products.
The School of Biomedical Engineering at the University of British Columbia was established in 2017. We are founded through partnerships with more than 20 joint faculty members that are leaders in research areas from molecular and cellular engineering, to biological imaging, computational biology and human interfacing devices. With access to world-leading research infrastructure, and with close partnerships with our research intensive hospitals and local industry, the School aims to provide a clear route from the discovery of new fundamental biomedical technologies to their innovative application and development to benefit human health.
The University of British Columbia is a global centre for research and teaching, consistently ranked among the 40 best universities in the world. Since 1915, UBC’s West Coast spirit has embraced innovation and challenged the status quo. Its entrepreneurial perspective encourages students, staff and faculty to challenge convention, lead discovery and explore new ways of learning. At UBC, bold thinking is given a place to develop into ideas that can change the world.
The Peter Wall Institute for Advanced Studies at the University of British Columbia (UBC) provides funding opportunities and an intellectual environment scholars are free to pursue the collaborative exchange of ideas beyond disciplinary boundaries.
The Institute’s goal is to stimulate creative, innovative research that makes important advances in knowledge, and to share or implement these ideas through ongoing community engagement. The Institute achieves this by supporting a highly collaborative environment at UBC where scholars have the opportunity to exchange ideas with national and international scholars, develop new thinking and engage in intellectual risk-taking.
2019 SPONSORS
Thank you to all our sponsors for PFT3D 2019!
